Product Explainer

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

Description

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).1

Reference: 1. AREXVY Product Information

This video was developed by Heathed with funding from GSK.
Views of the speaker are their own and do not necessarily reflect that of GSK. GSK recommends usage in accordance with the Product Information.

PM-AU-RSA-WCNT-240007 Date of approval: March 2024.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ralph Audehm

A/Prof Ralph Audehm

Lipids Management in GP Demystified

Dr Anita Munoz

Dr Anita Munoz

Maintaining Muscles of Independence – Sarcopenia Screening & Management

Dr Melissa Bochner

Dr Melissa Bochner

Work Up of a Breast Lump in GP – Practical Tips and Traps

Dr Adam Straub

Dr Adam Straub

Managing Opioid Dependence in GP – An Update

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

A/Prof Michael Woodward AM

expert

A/Prof Michael Woodward AM

Geriatrician; Head of Aged Care and Memory Clinic, Austin Health

Date published: 9 March 2024